Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
44 drugs in development
By Therapeutic Area
top 6
R&D Momentum
99/100
Pipeline Velocity
81/100
Trial Completion Rate
77/100
Pipeline Concentration
25/100
Pipeline Freshness
66/100
Strategic Signals
Activity
Last 14 days
Parents ASSIST for All LGBTQ Youth (Hillman)
Phase 1 Study of huCART19-IL18-eDHFR Cells in Patients With Relapsed or Refractory Follicular Lymphoma
Posterior Cingulate Cortex and Executive Control of Episodic Memory
Randomized Trial of Universal vs. Guideline-directed Germline Testing Among Young Adults With Cancer
Validation of the Vision Trainer Clinical Decision-Support Software:A Randomized Comparison of Software-Guided Subjective Refraction(JCC and Non-JCC Algorithms) Against Unassisted Manual Refraction
Sequential Multiple Assignment Randomized Trial Comparing Commonly Prescribed and Over the Counter Medications for the Treatment of Insomnia in Adults
Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI
Study On The Effect of Combined Use of a Connected Pillbox, Pre-filled Medication Trays, Automated Text Message/Phone Call Reminds, On Medication Adherence in Patients With Type II Diabetes Mellitus, Hypertension or Hyperlipidemia
Traumatic Hemothorax Treatment With 14-Fr Pigtail Catheters or Large Bore (~28Fr) Chest Tubes With Daily Irrigation: A Pilot Single-Arm Intervention Study
Validation of NAD+ Measurements for Human Clinical Studies: Multi-method Inter-laboratory Standardization
Group Preconception Care for Fertility Patients
A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)